Broad and potent neutralizing antibodies from an african donor reveal a new HIV-1 vaccine target

Science

Volumn 326, Issue 5950, 2009, Pages 285-289

  Burton, Dennis R ^a,e   Walker, Laura M ^a   Phogat, Sanjay K ^b   Chan Hui, Po Ying ^c   Wagner, Denise ^b   Phung, Pham ^d   Goss, Julie L ^d   Wrin, Terri ^b   Simek, Melissa D ^a   Fling, Steven ^c   Mitcham, Jennifer L ^b   Lehrman, Jennifer K ^b   Priddy, Frances H ^c   Olsen, Ole A ^c   Frey, Steven M ^c   Hammond, Phillip W ^c   Protocol, G ^f   Kaminsky, Stephen ^b   Zamb, Timothy ^b   Moyle, Matthew ^c   Koff, Wayne C ^b   Poignard, Pascal ^a   more..

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b INTERNATIONAL AIDS VACCINE INITIATIVE   (United States)

^c Theraclone Sciences   (United States)

^d MONOGRAM BIOSCIENCES   (United States)

^e MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^f Massachusetts Institute of Technology and Harvard ^*

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN; EPITOPE; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY;

ANTIBODY; CLADISTICS; DISEASE CONTROL; HUMAN IMMUNODEFICIENCY VIRUS; INFECTIOUS DISEASE; PROTEIN; VACCINE; VIRUS;

AMINO ACID SUBSTITUTION; ANTIGEN BINDING; ANTIVIRAL ACTIVITY; ARTICLE; CLADISTICS; CONTROLLED STUDY; DRUG DESIGN; DRUG POTENCY; DRUG TARGETING; EPITOPE MAPPING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IC 50; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; VIRUS NEUTRALIZATION;

AFRICA SOUTH OF THE SAHARA; AIDS VACCINES; ANTIBODIES, MONOCLONAL; B-LYMPHOCYTE SUBSETS; EPITOPES; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV ENVELOPE PROTEIN GP41; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; NEUTRALIZATION TESTS; PEPTIDE FRAGMENTS; PROTEIN MULTIMERIZATION; RECOMBINANT PROTEINS;

CERCOPITHECINE HERPESVIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 70349887757     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1178746     Document Type: Article

References (25)

1. M. I. Johnston, A. S. Fauci, N. Engl. J. Med. 356,2073 (2007).
2. D. H. Barouch, Nature 455, 613 (2008).
3. B. D. Walker, D. R. Burton, Science 320, 760 (2008).
4. R. S. Veazey et al., Nat. Med. 9, 343 (2003).
5. A. J. Hessell et al., PLoS Pathog. 5, e1000433 (2009).
6. P. W. Parren et al., J. Virol. 75, 8340 (2001).
7. J. R. Mascola, Vaccine 20, 1922 (2002).
8. J. R. Mascola et al., Nat. Med. 6, 207 (2000).
9. J. R. Mascola et al., J. Virol. 73, 4009 (1999).
10. S. Phogat, R. Wyatt, Curr. Pharm. Des. 13, 213 (2007).
11. M. Montera, N. E. van Houten, X. Wang, J. K. Scott, Microbiol. Mol. Biol. Rev. 72, 54 (2008).
12. C. N. Scanlan, J. Offer, N. Zitzmann, R. A. Dwek, Nature 446, 1038 (2007).
13. M. D. Simek et al., J. Virol. 83, 7337 (2009).
14. L Stamatatos, L Morris, D. R. Burton, J. R. Mascola, Nat. Med. 15, 866 (2009).
15. Materials and methods are available as supporting material on Science Online.
16. Y. Ichiyoshi, P. Casali, J. Exp. Med. 180, 885 (1994).
17. W. J. Honnen et al., J. Virol. 81, 1424 (2007).
18. A. Pinter et al., J. Virol. 79, 6909 (2005).
19. M. Pancera, R. Wyatt, Virology 332, 145 (2005).
20. R. Pantophlet et al., J. Virol. 77, 642 (2003).
21. R. Pantophlet, M. Wang, R. O. Aguilar-Sino, D. R. Burton, J. Virol. 83, 1649 (2009).
22. R. Darbha et al., Biochemistry 43, 1410 (2004).
23. C. N. Scanlan et al., J. Virol. 76, 7306 (2002).
24. M. K. Gorny et al., J. Virol. 79, 5232 (2005).
25. 2gp140- foldon trimer. This work was supported by the International AIDS Vaccine Initiative (IAVI) through the contributions of a number of government and private donors who are listed on the Web site www.iavi.org, as well as IAVI's Innovation Fund (which is cofunded by the Bill & Melinda Gates Foundation); the U.S. Agency for International Development (USAID); and the National Institute of Allergy and Infectious Diseases, NIH, AI33292 (D.R.B.). The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the U.S. government. The authors declare competing financial interests. Protocol G Principal Investigators: G. Miiro, J. Serwanga, A. Pozniak, D. McPhee, O. Manigart, L Mwananyanda, E. Karita, A. Inwoley, W. Jaoko, J. DeHovitz, L G. Bekker, P. Pitisuttithum, R. Paris, and S. Allen.